相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advances in genome editing for genetic hearing loss
Ning Ding et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment
Gibran Ali et al.
GENE THERAPY (2021)
Inhalation delivery technology for genome-editing of respiratory diseases
Michael Y. T. Chow et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Research on CRISPR/system in major cancers and its potential in cancer treatments
Z. Liu et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
Induced Liver Regeneration Enhances CRISPR/Cas9-Mediated Gene Repair in Tyrosinemia Type 1
Qing-Shuo Zhang et al.
HUMAN GENE THERAPY (2021)
Microbial Base Editing: A Powerful Emerging Technology for Microbial Genome Engineering
Yu Wang et al.
TRENDS IN BIOTECHNOLOGY (2021)
Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing
Qiubing Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
CRISPR technology: The engine that drives cancer therapy
Mingtao Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
CRISPR-based tools: Alternative methods for the diagnosis of COVID-19
Fahreddin Palaz et al.
CLINICAL BIOCHEMISTRY (2021)
CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19
Majid Vatankhah et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2021)
CRISPR/Cas9 gene editing for curing sickle cell disease
So Hyun Park et al.
TRANSFUSION AND APHERESIS SCIENCE (2021)
Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy
Vratko Himic et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2021)
Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice
Sam Hana et al.
GENE THERAPY (2021)
Genome editing for Duchenne muscular dystrophy: a glimpse of the future?
Christian Kupatt et al.
GENE THERAPY (2021)
CRISPR/Cas9-Mediated Gene Correction in Newborn Rabbits with Hereditary Tyrosinemia Type I
Nan Li et al.
MOLECULAR THERAPY (2021)
Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer
Samantha M. Fix et al.
CANCER DISCOVERY (2021)
Analysis of Pathogenic Variants Correctable With CRISPR Base Editing Among Patients With Recessive Inherited Retinal Degeneration
Lewis E. Fry et al.
JAMA OPHTHALMOLOGY (2021)
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
Kelvin Kai-Wang To et al.
EMERGING MICROBES & INFECTIONS (2021)
Genome-editing approaches and applications: a brief review on CRISPR technology and its role in cancer
Narmadhaa Siva et al.
3 BIOTECH (2021)
Rapid, Ultrasensitive, and Highly Specific Diagnosis of COVID-19 by CRISPR-Based Detection
Xiong Zhu et al.
ACS SENSORS (2021)
Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells
Christi T. Salisbury-Ruf et al.
JOURNAL OF CLINICAL MEDICINE (2021)
CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing
Ishani Dasgupta et al.
HUMAN GENE THERAPY (2021)
Revisiting cell and gene therapies in Huntington's disease
Margarida Beatriz et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2021)
CRISPR technologies for the treatment of Duchenne muscular dystrophy
Eunyoung Choi et al.
MOLECULAR THERAPY (2021)
Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes
Chunlong Xu et al.
NATURE METHODS (2021)
An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing
Kean Hean Ooi et al.
NATURE COMMUNICATIONS (2021)
Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
James B. Papizan et al.
JOURNAL OF BIOMEDICAL RESEARCH (2021)
SHERLOCK and DETECTR: CRISPR-Cas Systems as Potential Rapid Diagnostic Tools for Emerging Infectious Diseases
Mujahed Mustafa et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
The Challenges of Medical Ethics in China: Are Gene-Edited Babies Enough?
Zeng Jie Ye et al.
SCIENCE AND ENGINEERING ETHICS (2020)
Translatable gene therapy for lung cancer using Crispr CAS9-an exploratory review
Jishnu Nair et al.
CANCER GENE THERAPY (2020)
CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment
Hui Xing et al.
ACTA PHARMACOLOGICA SINICA (2020)
CRISPR/Cas9: targeted genome editing for the treatment of hereditary hearing loss
Rimsha Farooq et al.
JOURNAL OF APPLIED GENETICS (2020)
CRISPR TREATMENT INSERTED DIRECTLY INTO BODY FOR THE FIRST TIME
Heidi Ledford
NATURE (2020)
'Off-the-shelf' allogeneic CAR T cells: development and challenges
S. Depil et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
CRISPR-Based Therapeutic Genome Editing: Strategies and In Vivo Delivery by AAV Vectors
Dan Wang et al.
CELL (2020)
Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza
Timothy R. Abbott et al.
CELL (2020)
CRISPR/Cas Systems in Genome Editing: Methodologies and Tools for sgRNA Design, Off-Target Evaluation, and Strategies to Mitigate Off-Target Effects
Hakim Manghwar et al.
ADVANCED SCIENCE (2020)
CRISPR/Cas9 gene editing: A new therapeutic approach in the treatment of infection and autoimmunity
Iraj Mohammadzadeh et al.
IUBMB LIFE (2020)
Pronuclear Microinjection during S-Phase Increases the Efficiency of CRISPR-Cas9-Assisted Knockin of Large DNA Donors in Mouse Zygotes
Takaya Abe et al.
CELL REPORTS (2020)
CRISPR Tools To Control Gene Expression in Bacteria
Antoine Vigouroux et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2020)
CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells
Ping Lin et al.
MOLECULAR CELL (2020)
CRISPR off-target detection with DISCOVER-seq
Beeke Wienert et al.
NATURE PROTOCOLS (2020)
Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA
Zongliang Gao et al.
NUCLEIC ACIDS RESEARCH (2020)
CRISPR/Cas systems to overcome challenges in developing the next generation of T cells for cancer therapy
Dennis Huang et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Advances in Alpha-1 Antitrypsin Gene Therapy
Reka Lorincz et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)
Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing
Neil T. Sullivan et al.
FRONTIERS IN MICROBIOLOGY (2020)
Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing
Giulia Maule et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
CRISPR/Cas9 novel therapeutic road for the treatment of neurodegenerative diseases
Ansar Karimian et al.
LIFE SCIENCES (2020)
Current Status and Challenges of DNA Base Editing Tools
You Kyeong Jeong et al.
MOLECULAR THERAPY (2020)
The delivery challenge: fulfilling the promise of therapeutic genome editing
Joost van Haasteren et al.
NATURE BIOTECHNOLOGY (2020)
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
Ariel Kantor et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors
Karim Shalaby et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Application of different types of CRISPR/Cas-based systems in bacteria
Zhenquan Liu et al.
MICROBIAL CELL FACTORIES (2020)
Electroporation and genetic supply of Cas9 increase the generation efficiency of CRISPR/Cas9 knock-in alleles in C57BL/6J mouse zygotes
Samy Alghadban et al.
SCIENTIFIC REPORTS (2020)
Novel Therapeutic Approaches for the Treatment of Retinal Degenerative Diseases: Focus on CRISPR/Cas-Based Gene Editing
Carmen Gallego et al.
FRONTIERS IN NEUROSCIENCE (2020)
CRISPR-Cas13a Inhibits HIV-1 Infection
Lijuan Yin et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
CRISPR/Cas9 Delivery Potentials in Alzheimer's Disease Management: A Mini Review
Amira Sayed Hanafy et al.
PHARMACEUTICS (2020)
CRISPR/Cas9: A powerful genome editing technique for the treatment of cancer cells with present challenges and future directions
Abu Hazafa et al.
LIFE SCIENCES (2020)
CRISPR based editing of SIV proviral DNA in ART treated non-human primates
Pietro Mancuso et al.
NATURE COMMUNICATIONS (2020)
CRISPR/Cas13: A potential therapeutic option of COVID-19
Melika Lotfi et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
The novel insight into the outcomes of CRISPR/Cas9 editing intra- and inter-species
Jiasong Chang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets
Imran Noorani et al.
GENOME BIOLOGY (2020)
Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases
Shao-Shuai Wu et al.
THERANOSTICS (2020)
Computational approaches for effective CRISPR guide RNA design and evaluation
Guanqing Liu et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)
Modulation of immune responses in lentiviral vector-mediated gene transfer
Andrea Annoni et al.
CELLULAR IMMUNOLOGY (2019)
Avoiding the off-target effects of CRISPR/cas9 system is still a challenging accomplishment for genetic transformation
Roberto H. Herai
GENE (2019)
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy
Christopher E. Nelson et al.
NATURE MEDICINE (2019)
Identification of preexisting adaptive immunity to Cas9 proteins in humans
Carsten T. Charlesworth et al.
NATURE MEDICINE (2019)
Improving CRISPR Genome Editing by Engineering Guide RNAs
Su Bin Moon et al.
TRENDS IN BIOTECHNOLOGY (2019)
Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
Qiaoqiao Xiao et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Optimizing genome editing strategy by primer-extension-mediated sequencing
Jianhang Yin et al.
CELL DISCOVERY (2019)
A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9
Basudeb Maji et al.
CELL (2019)
Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases
Panayiota Papasavva et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
In utero gene editing for monogenic lung disease
Deepthi Alapati et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
Shayesteh R. Ferdosi et al.
NATURE COMMUNICATIONS (2019)
Rationally Designed Small Nucleic Acid-Based Inhibitors of CRISPR-Cas9
Christopher L. Barkau et al.
NUCLEIC ACID THERAPEUTICS (2019)
A cytosine deaminase for programmable single-base RNA editing
Omar O. Abudayyeh et al.
SCIENCE (2019)
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites
Rajeswari Jayavaradhan et al.
NATURE COMMUNICATIONS (2019)
Gold Nanocluster-Mediated Efficient Delivery of Cas9 Protein through pH-Induced Assembly-Disassembly for Inactivation of Virus Oncogenes
Enguo Ju et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Anti-CRISPR-Associated Proteins Are Crucial Repressors of Anti-CRISPR Transcription
Sabrina Y. Stanley et al.
CELL (2019)
China approves ethics advisory group after CRISPR-babies scandal
Hepeng Jia
NATURE (2019)
CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia
Lei Xu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone et al.
NATURE (2019)
Elimination of infectious HIV DNA by CRISPR-Cas9
Atze T. Das et al.
CURRENT OPINION IN VIROLOGY (2019)
Somatic Gene Editing of GUCY2D by AAV-CRISPR/Cas9 Alters Retinal Structure and Function in Mouse and Macaque
K. Tyler McCullough et al.
HUMAN GENE THERAPY (2019)
High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population
Dimitrios L. Wagner et al.
NATURE MEDICINE (2019)
A universal method for sensitive and cell-free detection of CRISPR-associated nucleases
Kurt J. Cox et al.
CHEMICAL SCIENCE (2019)
Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq
Beeke Wienert et al.
SCIENCE (2019)
CRISPR-Cas Biology and Its Application to Infectious Diseases
Jeffrey R. Strich et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework
Shahad K. Alsaiari et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents
Xue Gao et al.
NATURE (2018)
Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency
Marella D. Canny et al.
NATURE BIOTECHNOLOGY (2018)
Immunity to CRISPR Cas9 and Cas12a therapeutics
Wei Leong Chew
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2018)
Enhanced Cytosolic Delivery and Release of CRISPR/Cas9 by Black Phosphorus Nanosheets for Genome Editing
Wenhua Zhou et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Active Intracellular Delivery of a Cas9/sgRNA Complex Using Ultrasound-Propelled Nanomotors
Malthe Hansen-Bruhn et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities
Ling Li et al.
BIOMATERIALS (2018)
Delivering CRISPR: a review of the challenges and approaches
Christopher A. Lino et al.
DRUG DELIVERY (2018)
Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development
Shalini Andersson et al.
DRUG DISCOVERY TODAY (2018)
CRISPR RNAs trigger innate immune responses in human cells
Sojung Kim et al.
GENOME RESEARCH (2018)
CRISPR/Cas9 Inhibits Multiple Steps of HIV-1 Infection
Lijuan Yin et al.
HUMAN GENE THERAPY (2018)
Genome editing by natural and engineered CRISPR-associated nucleases
Wen Y. Wu et al.
NATURE CHEMICAL BIOLOGY (2018)
In vivo base editing of post-mitotic sensory cells
Wei-Hsi Yeh et al.
NATURE COMMUNICATIONS (2018)
A CRISPRi screen in E. coli reveals sequence-specific toxicity of dCas9
Lun Cui et al.
NATURE COMMUNICATIONS (2018)
Break Breast Cancer Addiction by CRISPR/Cas9 Genome Editing
Haitao Yang et al.
JOURNAL OF CANCER (2018)
Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
Yinnan Chen et al.
ADVANCED SCIENCE (2018)
Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
Vijaya L. Simhadri et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d
Cheng Zhang et al.
CELL (2018)
A global observatory for gene editing
Sheila Jasanoff et al.
NATURE (2018)
Evolved Cas9 variants with broad PAM compatibility and high DNA specificity
Johnny H. Hu et al.
NATURE (2018)
CRISPR-Cas guides the future of genetic engineering
Gavin J. Knott et al.
SCIENCE (2018)
Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA
Jason B. Miller et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
CRISPR-offinder: a CRISPR guide RNA design and off-target searching tool for user-defined protospacer adjacent motif
Changzhi Zhao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Toward Responsible Human Genome Editing
Richard O. Hynes et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting
Seung Min Kim et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase Differentially Regulated by Accessory Proteins Csx27 and Csx28
Aaron A. Smargon et al.
MOLECULAR CELL (2017)
CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo
Lei Xu et al.
MOLECULAR THERAPY (2017)
Enhanced proofreading governs CRISPR-Cas9 targeting accuracy
Janice S. Chen et al.
NATURE (2017)
Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions
Y. Bill Kim et al.
NATURE BIOTECHNOLOGY (2017)
Diversity and evolution of class 2 CRISPR-Cas systems
Sergey Shmakov et al.
NATURE REVIEWS MICROBIOLOGY (2017)
Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression
Taeyoung Koo et al.
NUCLEIC ACIDS RESEARCH (2017)
RNA editing with CRISPR-Cas13
David B. T. Cox et al.
SCIENCE (2017)
Extracellular Vesicles: Unique Intercellular Delivery Vehicles
Sybren L. N. Maas et al.
TRENDS IN CELL BIOLOGY (2017)
Inhibition of CRISPR-Cas9 with Bacteriophage Proteins
Benjamin J. Rauch et al.
CELL (2017)
CRISPR gene editing tested in a person
David Cyranoski
NATURE (2016)
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Keiichiro Suzuki et al.
NATURE (2016)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever et al.
NATURE (2016)
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Omar O. Abudayyeh et al.
SCIENCE (2016)
CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation
Xin Han et al.
SCIENCE ADVANCES (2015)
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Shengdar Q. Tsai et al.
NATURE BIOTECHNOLOGY (2015)
Low Incidence of Off-Target Mutations in Individual CRISPR-Cas9 and TALEN Targeted Human Stem Cell Clones Detected by Whole-Genome Sequencing
Adrian Veres et al.
CELL STEM CELL (2014)
Gene regulation by engineered CRISPR-Cas systems
Peter C. Fineran et al.
CURRENT OPINION IN MICROBIOLOGY (2014)
A vector-free microfluidic platform for intracellular delivery
Armon Sharei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Adenoviral Vector Immunity: Its Implications and Circumvention Strategies
Yadvinder S. Ahi et al.
CURRENT GENE THERAPY (2011)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
Mechanism and regulation of human non-homologous DNA end-joining
MR Lieber et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
分享论文
